Evidence map›Paper›PMID 22333577›Full record

ReviewCell cycle (Georgetown, Tex.)2012

Adult stem cells underlying lung regeneration.

Wa Xian, Frank McKeon

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Senescence and autophagy in usual interstitial pneumonia of different etiology.Virchows Archiv : an international journal of pathology · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Brg1 determines urothelial cell fate during ureter development.Journal of the American Society of Nephrology : JASN · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Wa XianInstitute of Medical Biology, A-STAR, Singapore. wa.xian@imb.a-star.edu.sg
Frank McKeon
Agency for Science, Technology and Research · SGBrigham and Women's Hospital · US

Funding

Epithelial Stem Cell ProgramsR01GM083348 · NIGMS · HARVARD MEDICAL SCHOOL · PI MCKEON, FRANK D. · 2008 to 2011
$1.5M
Monoclonal Antibodies and Genetic Elements for Airway DiseaseRC1HL100767 · NHLBI · HARVARD MEDICAL SCHOOL · PI MCKEON, FRANK D. · 2009 to 2010
$994k
p53 signatures and pelvic serous carcinomaR21CA124688 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRUM, CHRISTOPHER PAUL · 2007 to 2009
$420k
NCI NIH HHS R21 CA124688NCI NIH HHS R21CA124688NHLBI NIH HHS RC1 HL100767NIGMS NIH HHS R01 GM083348NIGMS NIH HHS R01-GM083348
6 · The paper itself

Abstract

Despite the massive toll in human suffering imparted by degenerative lung disease, including COPD, idiopathic pulmonary fibrosis and ARDS, the scientific community has been surprisingly agnostic regarding the potential of lung tissue, and in particular the alveoli, to regenerate. However, there is circumstantial evidence in humans and direct evidence in mice that ARDS triggers robust regeneration of lung tissue rather than irreversible fibrosis. The stem cells responsible for this remarkable regenerative process has garnered tremendous attention, most recently yielding a defined set of cloned human airway stem cells marked by p63 expression but with distinct commitment to differentiated cell types typical of the upper or lower airways, the latter of which include alveoli-like structures in vitro and in vivo. These recent advances in lung regeneration and distal airway stem cells and the potential of associated soluble factors in regeneration must be harnessed for therapeutic options in chronic lung disease.

Indexed as

RegenerationAdult Stem CellsAnimalsHumansIdiopathic Pulmonary FibrosisKeratin-5LungPulmonary Disease, Chronic ObstructiveRespiratory Distress SyndromeTumor Suppressor ProteinsKeratin-5Tumor Suppressor Proteins

Identifiers

PMID22333577
PMCPMC3323794
OpenAlexW1980637877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.